Can STDs Affect Your Heart? What the Evidence Actually Shows

Certain STDs can cause heart and cardiovascular damage — but this isn’t a vague theoretical risk. It’s a specific, well-documented complication of one infection in particular: syphilis. Understanding which STDs actually carry cardiovascular risk, and what that risk looks like clinically, puts the concern in proper perspective.

Quick answer: Syphilis causes documented cardiovascular damage in its tertiary stage — specifically aortitis leading to aortic aneurysm and valve disease. HIV increases cardiovascular risk through chronic immune activation and inflammation. Chlamydia and gonorrhea do not directly damage the heart. HIV treatment dramatically reduces this risk. If you have any STD history and cardiovascular symptoms, same-day evaluation is warranted. Testing available in Houston, Los Angeles, New York City, Atlanta, and Washington DC.

Syphilis and Cardiovascular Disease

Tertiary syphilis — the late stage that develops in approximately 30% of untreated cases, typically 10–30 years after initial infection — includes cardiovascular syphilis as one of its three major manifestations. The mechanism: Treponema pallidum infects the vasa vasorum (small blood vessels supplying the aortic wall), causing progressive aortitis — inflammation of the aorta. This leads to weakening and dilation of the aortic wall, potentially progressing to aortic aneurysm and, through the same inflammatory process, aortic valve incompetence as the aortic root dilates and prevents the valve from closing properly.

The clinical presentation includes the aortic regurgitation murmur of valve incompetence; chest or back pain from aneurysm; and in severe cases, heart failure. The window for prevention is the same as for all tertiary syphilis: treatment with penicillin at primary, secondary, or latent stages. Cardiovascular damage from tertiary syphilis is not reversible with antibiotic treatment — it requires cardiac surgical management in advanced cases.

HIV and Cardiovascular Risk

HIV significantly increases cardiovascular disease risk, and the mechanism is primarily immune activation rather than direct cardiac infection. People with HIV have higher rates of myocardial infarction (heart attack), stroke, and heart failure compared to HIV-negative individuals of the same age, even when antiretroviral therapy maintains viral suppression.

The pathophysiology involves chronic immune activation and systemic inflammation that accelerates atherosclerosis — the process of plaque deposition in arterial walls. Some older antiretroviral drugs (particularly protease inhibitors) contribute to dyslipidaemia (abnormal cholesterol levels) that further increases cardiovascular risk. Modern antiretroviral regimens are generally much better in this regard. Effective ART dramatically reduces HIV-related cardiovascular risk compared to untreated infection — the highest cardiovascular risk is in people with uncontrolled HIV and low CD4 counts, not in people on effective treatment.

Chlamydia, Gonorrhea, and the Heart

Chlamydia and gonorrhea do not directly cause heart disease. Both cause systemic inflammation during active infection, and chronic inflammation is a risk factor for cardiovascular disease in general — but this is a population-level statistical association, not a specific mechanism of cardiac damage comparable to syphilitic aortitis or HIV-driven inflammation. Treating and clearing these infections removes the inflammatory stimulus.

When to Seek Urgent Evaluation

• Chest pain or back pain in someone with known syphilis history or late-stage disease: emergency evaluation for aortic involvement.

• New heart murmur in someone with positive syphilis serology: cardiology and infectious disease referral same day.

• Shortness of breath, palpitations, or syncope in someone with HIV: cardiac evaluation warranted.

Frequently Asked Questions

Can chlamydia cause heart problems?

Not directly. Chlamydia doesn’t infect cardiac tissue in the same way syphilis does. There is epidemiological research exploring associations between Chlamydia pneumoniae (a respiratory pathogen, distinct from the sexually transmitted Chlamydia trachomatis) and cardiovascular disease, but sexual chlamydia is not an established cardiac risk factor.

Does treating syphilis reverse heart damage?

Antibiotics eliminate the active bacterial infection and stop further damage, but structural damage already done — aortic aneurysm, valve incompetence — cannot be reversed by penicillin. This is why early treatment at primary or secondary stage is so important: it prevents the tertiary complications from developing at all.

Does HIV treatment reduce cardiovascular risk?

Yes, substantially. Effective ART reduces the chronic immune activation that drives HIV-associated cardiovascular risk. People with well-controlled HIV on modern regimens have much lower cardiovascular risk than those with uncontrolled infection, though some residual elevation compared to HIV-negative individuals persists even with treatment.

Related: Syphilis: Stages and Treatment · Understanding HIV · STDs and Joints · STDs and Vision · Get tested today →